Genomics is defined as the study of the structure, function,
and inheritance of the genetic material exist in the deoxyribonucleic acid
(DNA) of an organism. It addresses the intrarelationship of all genes to discover
their combined impact on the overall growth and development. It includes several
consumables, systems, software and services for diagnostics, drug discovery,
development of precision medicine and agricultural research. Few of the technologies used
for genomics are microarray, polymerase chain reaction (PCR), sequencing,
nucleic acid extraction and purification and single-cell genomics analysis. The
key factors accounted for the growth of the genomics market are rising
government support and surged number of genomics studies, reducing sequencing
cost, increased genomics applications. The genomics market is geared to rapid
growth as a result of the vital genetic developments and also because of its
applications in numerous areas of study, such as intragenomic phenomena, which
include heterosis, epistasis, pleiotropy, and other associations within the
genome between alleles and loci. Moreover, there are some more factors which
are playing prominent roles in taking the genomics market to the next level;
among them, one is on-bioengineering and synthetic biology applications, which
are anticipated to further accelerate the growth of the genomics market. In Addition, the governments in several
countries are investigating in research and developments in the area of
genomics for development of new technologies. For examle, in January 2020, the
Department of Biotechnology (DBT) commenced the “Genome India Project” (GIP) in
India. In this project, 10,000 genetic samples of Indian citizen will be accumulated
to build a reference genome. This project is intended to the precision health,
mutation spectrum of genetic and complex diseases, genetic epidemiology of
multifactorial lifestyle diseases, rare genetic disorders, and translational
research. Such initiatives are projected to increase the usage of genomics
products, which will propel the overall market growth. Moreover, the factors
which are restraining the market are high price of genomics equipment and lack
of trained workforce.
Furthermore,
the rise in the personalized medicine market is set to provide an array of
opportunities for players in the genomics market. Several pharmaceutical companies
are highly investing in personalized medicine research. Personalized medicine allows
medical practitioners to identify the precise requirements of a patient and
then prescribe medicines and treatments accordingly. This approach assures
better care outcomes. In addition to this, it is anticipated that advancements
in the field of gene therapy have the potential to replace conventional drugs
and surgeries by allowing doctors to treat a disorder by inserting a gene into
a patient’s cell.
The
global Genomics Market is segregated on the basis of Product and Service as Systems
& Software, Consumables and Services. Based on Technology the global Genomics
Market is segmented in Sequencing, Microarray and PCR. Based on Application the
global Genomics Market is segmented in Diagnostic Application and Precision
Medicine.
The
global Genomics Market report provides geographic analysis covering regions,
such as Europe, North America, Asia Pacific, and Rest of The World. The Genomics
Market for each region is further segmented for major countries including the
U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil,
South Africa, and others.
Competitive Analysis
Thermo
Fisher Scientific, Inc., Agilent Technologies, Beijing Genomics Institute (BGI),
Bio-Rad Laboratories, Danaher Corporation and others are among the major
players in the global Genomics Market. The companies studied in terms of
product strategy and various n several growth and expansion strategies to gain
a competitive edge in the market. The major players not only follow value chain
integration with business operations in multiple stages of the value chain.
- In 2021,
Illumina (US) partnered with Helix OpCo (US) to enhance the national
surveillance infrastructure in the US so as to track the emergence and incidence
of new strains of SARS-CoV-2 with support from the CDC. Illumina’s sequencing
technology and expertise and Helix’s national COVID-19 testing footprint will majorly
expand the country’s current surveillance efforts to identify and characterize
emerging variants of SARS-CoV-2.
- In 2020,
BGI (China) extended its DNA sequencing and laboratory automation products
available in Latin America by signing contracts with top distributors in
Brazil, Argentina, Ecuador, Peru, Colombia, and Mexico.
The global Genomics Market has been segmented as
below:
Genomics
Market, By Product And Service
- Systems & Software
- Consumables
- Services
Genomics
Market, By Technology
Genomics
Market, By Application
- Diagnostic Application
- Precision Medicine
Genomics
Market, By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
Genomics
Market, By Company
- Thermo Fisher Scientific, Inc.
- Agilent Technologies
- Beijing Genomics Institute (BGI)
- Bio-Rad Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Illumina, Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California,
Inc.
- QIAGEN N.V.
- Quest diagnostics
- Myriad Genetics, Inc.
- Eppendorf AG
- Eurofins Scientific
- Color
- 23andMe, Inc.
The
report covers the below scope:
- Global Genomics Market sizes from
2020 to 2026, along with CAGR for 2020-2026
- Market size comparison for 2019 vs
2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to
2026
- Global Genomics Market trends,
covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering
participants from raw material suppliers to the downstream buyer in the global Genomics
Market
- Major market opportunities and
challenges in forecast timeframe to be focused
- Competitive landscape with analysis
on competition pattern, portfolio comparisons, development trends and strategic
management
- Comprehensive company profiles of
the key industry players
The
years considered for the study are as follows:
- Base year - 2019
- Estimated year - 2019
- Projected year - 2020
- Forecast period - 2021 to 2026
Report
Scope:
The global Genomics Market report scope includes
detailed study covering underlying factors influencing the industry trends. The
report covers analysis on regional and country level market dynamics. The scope
also covers competitive overview providing company market shares along with
company profiles for major revenue contributing companies. The report scope
includes detailed competitive outlook covering market shares and profiles key
participants in the global Genomics Market share. Major industry players with
significant revenue share include Thermo Fisher Scientific,
Inc., Agilent Technologies, Beijing Genomics Institute (BGI), Bio-Rad
Laboratories, Danaher Corporation and
others.
Why to
Buy this Report:
- Gain detailed insights on the Genomics
industry trends
- Find complete analysis on the
market status
- Identify the Genomics Market
opportunities and growth segments
- Analyse competitive dynamics by
evaluating business segments & product portfolios
- Facilitate strategy planning and
industry dynamics to enhance decision making
Target
Audience:
- The report targeted towards the existing players in
the industry is as follows:
- Market Manufacturers/Service
Providers
- Market Wholesale/Traders
- Investment and Financial
Institutions
Free
and Paid Customization based on the requirement